Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 695 |
---|---|
Genomic Coordinate (GRCh38) | g.22227571_22227572dup |
Variant | c.2030_2031dup |
Variant Start Position | 2030 |
Location | Exon 20 |
Amino Acid Change | p.Phe678Hisfs*10 |
ACMG Call | Pathogenic |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Pathogenic | Effect Type | Frameshift |
Variant Type | Small duplication |
PMID | 20157195, 34806794 |
Article Count | 2 |
Times Observed | < 3 |
Clinical Phenotype | - |
ACMG Categories | pvs1, pm2, ppc |
ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22245685 ref:T alt:TCA was not found in gnomAD exomes or genomes. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | ppc |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | X-22245685-T-TCA |
GnomAD Alleles | - |
DBNSFP Alleles | - |
Other Alleles | - |
Note | nan |
Warnings | - |